Trials / Completed

CompletedNCT00180336

Safety and Efficacy Study of RENEWAL 4 AVT

CONTAK RENEWAL 4 AVT Field Following

Status: Completed
Phase: Phase 2 / Phase 3
Study type: Interventional
Enrollment: 170 (planned)

Sponsor: Boston Scientific Corporation · Industry
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the safety and effectiveness of the CONTAK RENEWAL 4 AVT device.

Detailed description

This is a prospective, two-arm, non-randomized, multi-center European field following, designed to demonstrate the safety and effectiveness of the CONTAK RENEWAL 4 AVT device in humans.

Conditions

Heart Failure
Tachycardia
Atrial Fibrillation
Atrial Flutter
Ventricular Fibrillation

Interventions

Type	Name	Description
DEVICE	CRT-D

Timeline

Start date: 2004-07-01
First posted: 2005-09-16
Last updated: 2007-06-25

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00180336. Inclusion in this directory is not an endorsement.